Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) EBITDA (2016 - 2025)

Historic EBITDA for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $32.5 million.

  • Orthofix Medical's EBITDA rose 820.53% to $32.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.4 million, marking a year-over-year increase of 6405.78%. This contributed to the annual value of -$129.0 million for FY2024, which is 1474.17% up from last year.
  • As of Q3 2025, Orthofix Medical's EBITDA stood at $32.5 million, which was up 820.53% from $28.9 million recorded in Q2 2025.
  • Orthofix Medical's EBITDA's 5-year high stood at $41.6 million during Q4 2021, with a 5-year trough of -$60.5 million in Q1 2023.
  • Moreover, its 5-year median value for EBITDA was $5.0 million (2021), whereas its average is -$5.0 million.
  • Per our database at Business Quant, Orthofix Medical's EBITDA tumbled by 95114.64% in 2023 and then surged by 19822.6% in 2024.
  • Orthofix Medical's EBITDA (Quarter) stood at $41.6 million in 2021, then fell by 15.45% to $35.2 million in 2022, then tumbled by 161.43% to -$21.6 million in 2023, then crashed by 50.63% to -$32.5 million in 2024, then surged by 199.96% to $32.5 million in 2025.
  • Its last three reported values are $32.5 million in Q3 2025, $28.9 million for Q2 2025, and -$51.3 million during Q1 2025.